Table 2 CD seroprevalence and prevalence: results and comparison between the two cohorts
From: Celiac disease in autism spectrum disorder: data from an Italian child cohort
|  | CD-Cases (#) | Controls (#) | Prevalence – mean (%) | CI 95% (%) | Range of age (years) | Fisher’s exact test |
|---|---|---|---|---|---|---|
ASD cohort (our study) | ||||||
SEROPREVALENCE PREVALENCE | 8 5 | 188°1 218°2 | 4.08 2.24 | 1.95 to 7.98 0.81 to 5.29 | 1.6–12.8 1.6–12.8 | P-value* / OR (CI 95%) |
Healthy control group (Gatti et al.) | ||||||
SEROPREVALENCE PREVALENCE | 96 90 | 4220 5615 | 2.22 1.58 | 1.79 to 2.65 1.26 to 1.90 | 5.0–11.0 5.0–11.0 | 0.0810* / 1.871 (0.8953 to 3.749) 0.2862* / 1.431 (0.6174 to 3.431) |